Alpha Teknova, Inc. (TKNO) intrinsic value & 10-year financials

Alpha Teknova, Inc. (TKNO) has a Graham intrinsic value of $2.64 per share. At $7.08 on Oct 17, 2026, the stock trades 168% above that value. Over the last 7 fiscal years revenue grew 5.3% a year to $40.5M, with an average return on invested capital of -22.6%.

Graham intrinsic value
$2.64
Share price (Oct 17, 2026)
$7.08
Price vs Graham value
168% above
Market cap
$378.7M
Revenue (FY2025)
$40.5M
Revenue growth (7-yr CAGR)
5.3%
ROIC (10-yr avg)
-22.6%
Free cash flow (FY2025)
-$9.8M

TKNO 10-year financial history

Fiscal year Revenue Net income EPS (diluted) Free cash flow Operating margin ROIC
FY2025 $40.5M -$17.3M -$0.32 -$9.8M -41.9% -17.3%
FY2024 $37.7M -$26.7M -$0.57 -$13.5M -69.3% -26.4%
FY2023 $36.7M -$36.8M -$1.16 -$26.7M -96.9% -37.5%
FY2022 $41.4M -$47.5M -$1.69 -$55.5M -119.9% -57.7%
FY2021 $36.9M -$9.8M -$0.61 -$28.9M -32.5% -23.0%
FY2020 $31.3M $3.6M $0.16 -$3.0M 14.9% 26.2%
FY2019 — — — — — —

Source: annual 10-K filings on SEC EDGAR. Figures in USD.

Executive summary

Alpha Teknova, Inc. revenue growth over the past decade is N/A; insufficient history prevents a reliable 10-year CAGR calculation.

Alpha Teknova, Inc. has historically struggled to out-earn its cost of capital, averaging just -22.6% ROIC.

Alpha Teknova, Inc. capital allocation metrics are N/A for the decade; share count and net debt history are incomplete.

Benjamin Graham lens

Under Benjamin Graham's formula using SEC EDGAR fundamentals, Alpha Teknova, Inc. is modeled at 5.3% normalized earnings growth with a 5.1% bond-yield adjustment. The resulting Graham intrinsic value estimate is $2.64 per share.

TKNO stock: frequently asked questions

What is the intrinsic value of Alpha Teknova, Inc. (TKNO) stock?

Using Benjamin Graham's revised formula, V = EPS × (8.5 + 2g) × 4.4 / Y, with reported diluted earnings per share, a 5.3% normalized growth rate (capped at 15%) and a 5.1% AAA corporate bond yield, TKNO's intrinsic value is about $2.64 per share.

Is TKNO stock undervalued?

At $7.08 (close on Oct 17, 2026), TKNO trades 168% above its Graham value of $2.64. On Graham's terms the shares look fully priced. A formula is a starting point for research, not a recommendation.

Does Alpha Teknova, Inc. generate free cash flow?

Alpha Teknova, Inc. generated -$9.8M of free cash flow (operating cash flow minus capital expenditures) in fiscal 2025. Free cash flow was positive in 0 of the last 6 reported years.

What is TKNO's return on invested capital?

Average ROIC over the last 7 fiscal years was -22.6%, and average return on equity was -20.0%. Sustained ROIC above about 15% usually points to a durable competitive advantage.

Where does this TKNO data come from?

From Alpha Teknova, Inc.'s annual 10-K filings on SEC EDGAR. Prices are end-of-day snapshots; valuations are formula outputs, not investment advice.

Similar in vitro & in vivo diagnostic substances stocks